Valbenazine + Monoamine Oxidase Inhibitors (Maois) Interaction
Contraindicatedinteraction on record
Description
Concomitant use may increase monoamine neurotransmitter concentration in synapses, potentially leading to serotonin syndrome or attenuated treatment effect. Avoid use or within 14 days of discontinuing MAOI therapy.
Mechanism
Increased concentration of monoamine neurotransmitters in synapses
Source: NLP:valbenazine